Literature DB >> 10620014

Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF.

Y Ito1.   

Abstract

The Runt domain transcription factor PEBP2/CBF is a heterodimer of alpha and beta subunits. Of the three mammalian alpha subunit genes, which are homologues of the Drosophila gene runt, PEBP2alphaA/CBFA1 and PEBP2alphaB/AML1 are critical regulators of osteogenesis and haematopoiesis, respectively. A unique functional interaction between PEBP2alphaB/AML1 and Ets-1 was recently observed, and provides a clear example of context-dependent transcriptional regulation. An elaborate mechanism of cooperation between the two factors may represent a basis for tissue-specific gene expression, which is thought to be achieved by combinations of specific sets of transcription factors unique to each cell lineage or stage of differentiation. A possible molecular basis for the critical role(s) played by PEBP2/CBF in tissue determination is discussed in light of these observations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10620014     DOI: 10.1046/j.1365-2443.1999.00298.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  38 in total

1.  Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites.

Authors:  Sayyed K Zaidi; Andrew J Sullivan; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

2.  Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein.

Authors:  Claire K Inman; Na Li; Paul Shore
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development.

Authors:  J Y Choi; J Pratap; A Javed; S K Zaidi; L Xing; E Balint; S Dalamangas; B Boyce; A J van Wijnen; J B Lian; J L Stein; S N Jones; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  Domain analyses of the Runx1 transcription factor responsible for modulating T-cell receptor-beta/CD4 and interleukin-4/interferon-gamma expression in CD4(+) peripheral T lymphocytes.

Authors:  Ryuji Uchino
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

5.  RUNX1 permits E4orf6-directed nuclear localization of the adenovirus E1B-55K protein and associates with centers of viral DNA and RNA synthesis.

Authors:  Leslie J Marshall; Amy C Moore; Misao Ohki; Issay Kitabayashi; David Patterson; David A Ornelles
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

6.  Application of RUNX3 gene promoter methylation in the diagnosis of non-small cell lung cancer.

Authors:  Gui-Ping Yu; Yong Ji; Guo-Qiang Chen; Bin Huang; Kai Shen; Song Wu; Zhen-Ya Shen
Journal:  Oncol Lett       Date:  2011-10-19       Impact factor: 2.967

Review 7.  RUNX1/AML1: a central player in hematopoiesis.

Authors:  T Okuda; M Nishimura; M Nakao; Y Fujita
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

8.  Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms.

Authors:  Hee-Jun Wee; Gang Huang; Katsuya Shigesada; Yoshiaki Ito
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

9.  Distinct contributions of conserved modules to Runt transcription factor activity.

Authors:  Pegine B Walrad; Saiyu Hang; Genevieve S Joseph; Julia Salas; J Peter Gergen
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

10.  Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells.

Authors:  Sven Klunker; Mark M W Chong; Pierre-Yves Mantel; Oscar Palomares; Claudio Bassin; Mario Ziegler; Beate Rückert; Flurina Meiler; Mübeccel Akdis; Dan R Littman; Cezmi A Akdis
Journal:  J Exp Med       Date:  2009-11-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.